Boston Medical Sciences key facts
- Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making.
- Boston Medical Sciences’s last known valuation is $31.0M.
- It has raised $9.2M; the latest was Early Stage VC ($6.5M) in Oct 2024.
- Notable investors include Mitsubishi UFJ Capital, Global Brain, JIC Venture Growth Investments, Beyond Next Ventures, Meiji Yasuda Life Insurance Company — 9 tracked in total.
- Status: Privately Held (backing).
- ·Watch Boston Medical Sciences: the Monday email on marks, rounds and moves
Boston Medical Sciences funding rounds
No funding rounds for Boston Medical Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Boston Medical Sciences valuation
Boston Medical Sciences's last known valuation is $31 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Boston Medical Sciences investors
9 investors are on record for Boston Medical Sciences, including Mitsubishi UFJ Capital, Global Brain, JIC Venture Growth Investments and Beyond Next Ventures.
About Boston Medical Sciences
Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. The company's platform utilizes artificial intelligence to perform virtual bowel cleansing, which helps prepare the colon for examination without the traditional discomfort associated with laxatives, enabling healthcare providers with enhanced detection and treatment through technology.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2023
- Website
- b-ms.tech/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Boston Medical Sciences’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.